Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by EduardoSanchezon Feb 28, 2020 4:42pm
101 Views
Post# 30749189

RE:Crickets

RE:CricketsPatience! March will bring many catalysts. This story is just starting to get out. Many Fund manager meetings yesterday, lots of interest. This is just getting going. CoronaVirus is an absolute blessing for this company. It will put the spotlight on rapid point of care PCR solutions with open access. Governments will be throwing money at pandemic preparedness in the near future. Acquirers will be eyeing this opportunity to get this future pandemic business and will battling to snap  up a solution like Lexagene. 
<< Previous
Bullboard Posts
Next >>